AI Summary
We reviewed 3 live results for kiovig and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Pharmaceutical.
We found a partial set of results while TopFind keeps working on additional matches.
Comparison Table
Source: Takeda Malaysia
Description
Kiovig is a 10% human normal immunoglobulin solution for intravenous administration. It is used as replacement therapy for patients who cannot produce enough antibodies and as immunomodulatory therapy for autoimmune conditions.
Best for
replacement therapy, autoimmune disorders and hospitalized patients
Rating
Source: Takeda
Description
Kiovig is a 10% solution (100 mg/mL) of human normal immunoglobulin (IVIg) for intravenous or subcutaneous administration. It is used as replacement therapy for patients with primary immunodeficiency (PID) and secondary immunodeficiency (SID). Additionally, it acts as an immunomodulatory therapy for conditions such as immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome, Kawasaki disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN). The product is available in various vial sizes, including 1g, 2.5g, 5g, 10g, 20g, and 30g concentrations.
Best for
primary immunodeficiency replacement, CIDP and MMN treatment, Kawasaki disease management, intravenous immunoglobulin therapy and subcutaneous infusion preference
Rating
Source: Takeda
Description
Gammagard Liquid is the North American brand name for the same 10% human normal immunoglobulin solution as Kiovig. It is used to treat primary immunodeficiency (PI) in patients 2 years of age and older, and is specifically indicated for adults with Multifocal Motor Neuropathy (MMN). This prescription medicine provides a ready-to-use liquid formulation for infusion to help strengthen the immune system or manage autoimmune responses in neuromuscular diseases.
Best for
U.S. healthcare providers, adults with MMN, PI patients over 2 years and plasma-derived therapy
Rating
| Compare | Kiovig | Kiovig 100mg/mL Solution for Infusion | Gammagard Liquid (Immune Globulin Infusion 10%) |
|---|---|---|---|
| Source | Takeda Malaysia | Takeda | Takeda |
| Description | Kiovig is a 10% human normal immunoglobulin solution for intravenous administration. It is used as replacement therapy for patients who cannot produce enough antibodies and as immunomodulatory therapy for autoimmune conditions. | Kiovig is a 10% solution (100 mg/mL) of human normal immunoglobulin (IVIg) for intravenous or subcutaneous administration. It is used as replacement therapy for patients with primary immunodeficiency (PID) and secondary immunodeficiency (SID). Additionally, it acts as an immunomodulatory therapy for conditions such as immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome, Kawasaki disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN). The product is available in various vial sizes, including 1g, 2.5g, 5g, 10g, 20g, and 30g concentrations. | Gammagard Liquid is the North American brand name for the same 10% human normal immunoglobulin solution as Kiovig. It is used to treat primary immunodeficiency (PI) in patients 2 years of age and older, and is specifically indicated for adults with Multifocal Motor Neuropathy (MMN). This prescription medicine provides a ready-to-use liquid formulation for infusion to help strengthen the immune system or manage autoimmune responses in neuromuscular diseases. |
| Best for | replacement therapy, autoimmune disorders and hospitalized patients | primary immunodeficiency replacement, CIDP and MMN treatment, Kawasaki disease management, intravenous immunoglobulin therapy and subcutaneous infusion preference | U.S. healthcare providers, adults with MMN, PI patients over 2 years and plasma-derived therapy |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Kiovig from Takeda Malaysia."
I picked this because Offers a reliable imported alternative for Malaysian patients requiring standardized immunoglobulin replacement therapy.
Share this search
Related Finds